NEW YORK (GenomeWeb News) – MDxHealth today reported that its total revenues for full-year 2010 were flat with 2009 at €2.5 million ($3.4 million), as the firm sharply cut its net loss.
The Liege, Belgium-based molecular diagnostics firm reported revenues of nearly €2 million from products and services, up from around €1 million in 2009. Its grant revenues declined to €568,000 from €1.5 million.